Telecommunications Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecommunications Press Releases.

Press releases published on September 30, 2026

Sep. 30, 2026

MEXC Leads SOL and DOGE Market-Price Liquidity in CoinGecko's 2026 CEX Report

Indeterminate GlobeNewswire

Sep. 30, 2026

Ocugen to Participate in Upcoming Scientific Conferences

Indeterminate GlobeNewswire

Sep. 30, 2026

R1 Therapeutics expands Series A to $80.5 million to advance global Phase 2b program in hyperphosphatemia

Indeterminate GlobeNewswire

Sep. 30, 2026

Classiq Introduces Fault Tolerance Engine to Bridge Quantum Applications and Fault-Tolerant Hardware

Indeterminate GlobeNewswire

Sep. 30, 2026

EVerZom successfully completes CTA-enabling preclinical studies of EVerGel™ required to support a clinical trial application

Indeterminate GlobeNewswire

Sep. 30, 2026

More Than 1,600 Participants Anchor Calroy Health Sciences' Joint Formulation Research

Indeterminate GlobeNewswire

Sep. 30, 2026

GlobalFoundries Announces Conference Call to Review Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Sep. 30, 2026

FactSet Reports Results for Fourth Quarter and Fiscal 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

Indeterminate GlobeNewswire

Sep. 30, 2026

Pharmazz, Inc. Receives U.S. FDA IND Clearance to Initiate Phase 3 Clinical Trial of Sovateltide in Traumatic Brain Injury

Indeterminate GlobeNewswire

Sep. 30, 2026

Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)

Indeterminate GlobeNewswire

Sep. 30, 2026

Satellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

Sep. 30, 2026

Vema Hydrogen Expands Canadian Team as Pilot Testing Advances, Appointing Quebec-based Stephane Dallaire as CFO

Indeterminate GlobeNewswire

Sep. 30, 2026

10 Barrel Expands Salty Sips RTD Portfolio with New Blackberry Refresher

Indeterminate GlobeNewswire

Sep. 30, 2026

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation

Indeterminate GlobeNewswire

Sep. 30, 2026

Sono-Tek Announces Record $7.19 Million in Orders from Advanced Clean Energy Sector Customer

Indeterminate GlobeNewswire

Sep. 30, 2026

Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection

Indeterminate GlobeNewswire

Sep. 30, 2026

Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Northland Power Closes Financing for Two Battery Storage Projects in Poland

Indeterminate GlobeNewswire

Sep. 30, 2026

Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO

Indeterminate GlobeNewswire